|
Shoo Thoughts
Join Date: Oct 2013
Location: These Mountains
Posts: 2,308
|
Mushroom season will soon be upon us and I can't wait. Nothing beats roaming the fields with a broad grin on ya face, searching for our little fungi friends, bagging them, drying them out, jarring them, then looking at them, knowing you have dozens of incredible trips ahead.
I remember, many years ago, my friend and I went shroom picking but the grass was long so we got down on our hands and knees to look for them. We crawled through the fields, eating a few, bagging a few, crawled onwards, eating a few, bagging a few, and slowly we started to trip. Next thing I looked up and there was a huge bull not 4 feet away looking down on us. So we crawled in reverse in slow motion. Haha. Scared teh hell out of us.
The following won't be news to anyone who's tried shrooms, but for the rest - they're bloody good for you too:
Johns Hopkins study of ingredient in “magic mushrooms” found participants exhibited more “openness”
Release Date: September 29, 2011
A single high dose of the hallucinogen psilocybin, the active ingredient in so-called “magic mushrooms,” was enough to bring about a measureable personality change lasting at least a year in nearly 60 percent of the 51 participants in a new study, according to the Johns Hopkins researchers who conducted it.
Lasting change was found in the part of the personality known as openness, which includes traits related to imagination, aesthetics, feelings, abstract ideas and general broad-mindedness. Changes in these traits, measured on a widely used and scientifically validated personality inventory, were larger in magnitude than changes typically observed in healthy adults over decades of life experiences, the scientists say. Researchers in the field say that after the age of 30, personality doesn’t usually change significantly.
“Normally, if anything, openness tends to decrease as people get older,” says study leader Roland R. Griffiths, a professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine.
The research, approved by Johns Hopkins’ Institutional Review Board, was funded in part by the National Institute on Drug Abuse and published in the Journal of Psychopharmacology.
The study participants completed two to five eight-hour drug sessions, with consecutive sessions separated by at least three weeks. Participants were informed they would receive a “moderate or high dose” of psilocybin during one of their drug sessions, but neither they nor the session monitors knew when.
During each session, participants were encouraged to lie down on a couch, use an eye mask to block external visual distraction, wear headphones through which music was played and focus their attention on their inner experiences.
Personality was assessed at screening, one to two months after each drug session and approximately 14 months after the last drug session. Griffiths says he believes the personality changes found in this study are likely permanent since they were sustained for over a year by many.
Nearly all of the participants in the new study considered themselves spiritually active (participating regularly in religious services, prayer or meditation). More than half had postgraduate degrees. The sessions with the otherwise illegal hallucinogen were closely monitored and volunteers were considered to be psychologically healthy
“We don’t know whether the findings can be generalized to the larger population,” Griffiths says.
As a word of caution, Griffiths also notes that some of the study participants reported strong fear or anxiety for a portion of their daylong psilocybin sessions, although none reported any lingering harmful effects. He cautions, however, that if hallucinogens are used in less well supervised settings, the possible fear or anxiety responses could lead to harmful behaviors.
Griffiths says lasting personality change is rarely looked at as a function of a single discrete experience in the laboratory. In the study, the change occurred specifically in those volunteers who had undergone a “mystical experience,” as validated on a questionnaire developed by early hallucinogen researchers and refined by Griffiths for use at Hopkins. He defines “mystical experience” as among other things, “a sense of interconnectedness with all people and things accompanied by a sense of sacredness and reverence.”
Personality was measured on a widely used and scientifically validated personality inventory, which covers openness and the other four broad domains that psychologists consider the makeup of personality: neuroticism, extroversion, agreeableness and conscientiousness. Only openness changed during the course of the study.
Griffiths says he believes psilocybin may have therapeutic uses. He is currently studying whether the hallucinogen has a use in helping cancer patients handle the depression and anxiety that comes along with a diagnosis, and whether it can help longtime cigarette smokers overcome their addiction.
“There may be applications for this we can’t even imagine at this point,” he says. “It certainly deserves to be systematically studied.”
Along with the National Institute on Drug Abuse, this study was funded by the Council on Spiritual Practices, Heffter Research Institute and the Betsy Gordon Foundation.
Other Hopkins authors of the research include Matthew W. Johnson, Ph.D., and Katherine A. MacLean, Ph.D.
Single Dose of Hallucinogen May Create Lasting Personality Change - 09/29/2011
- - - - - - - - - - - - - - - - - -
And that's not all, no sir:
In their study, the Hopkins scientists were able to reliably induce transcendental experiences in volunteers, which offered long-lasting psychological growth and helped people find peace in their lives — without the negative effects.
“The important point here is that we found the sweet spot where we can optimize the positive persistent effects and avoid some of the fear and anxiety that can occur and can be quite disruptive,” says lead author Roland Griffiths, professor of behavioral biology at Hopkins.
Giffiths’ study involved 18 healthy adults, average age 46, who participated in five eight-hour drug sessions with either psilocybin — at varying doses — or placebo. Nearly all the volunteers were college graduates and 78% participated regularly in religious activities; all were interested in spiritual experience.
Fourteen months after participating in the study, 94% of those who received the drug said the experiment was one of the top five most meaningful experiences of their lives; 39% said it was the single most meaningful experience.
Critically, however, the participants themselves were not the only ones who saw the benefit from the insights they gained: their friends, family member and colleagues also reported that the psilocybin experience had made the participants calmer, happier and kinder.
http://healthland.time.com/2011/06/1...lth-long-term/
Last edited by Mr. Charlie; 08-24-2015 at 09:17 PM.
|
Linear Mode
